Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Efficient gene reframing therapy for recessive dystrophic epidermolysis bullosa using CRISPR/Cas9.

Takashima S, Shinkuma S, Fujita Y, Nomura T, Ujiie H, Natsuga K, Iwata H, Nakamura H, Vorobyev A, Abe R, Shimizu H.

J Invest Dermatol. 2019 Mar 1. pii: S0022-202X(19)30185-X. doi: 10.1016/j.jid.2019.02.015. [Epub ahead of print]

PMID:
30831133
2.

Linear immunoglobulin A/immunoglobulin G bullous dermatosis with autoantibodies to LAD-1 and laminin-γ1.

Matsudate Y, Yamasaki K, Ujiie H, Iwata H, Kubo Y.

Clin Exp Dermatol. 2019 Apr;44(3):e44-e46. doi: 10.1111/ced.13921. Epub 2019 Jan 28. No abstract available.

PMID:
30693555
3.

Clinical and immunological features of pemphigus relapse.

Ujiie I, Ujiie H, Iwata H, Shimizu H.

Br J Dermatol. 2018 Dec 26. doi: 10.1111/bjd.17591. [Epub ahead of print]

PMID:
30585310
4.

Case of autoimmune intraepidermal and subepidermal blistering disease in which autoantibodies to desmoglein 1 and BP230 coexist.

Sugai T, Ujiie H, Nakamura H, Kikuchi K, Iwata H, Shimizu H.

J Dermatol. 2018 Dec 14. doi: 10.1111/1346-8138.14734. [Epub ahead of print] No abstract available.

PMID:
30549100
5.

Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoid.

Iwata H, Kamaguchi M, Ujiie H, Ujiie I, Natsuga K, Nishie W, Shimizu H.

J Pathol. 2019 Mar;247(3):371-380. doi: 10.1002/path.5196. Epub 2019 Jan 16.

PMID:
30426510
6.

Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.

Zheng M, Ujiie H, Iwata H, Muramatsu K, Yoshimoto N, Ito T, Ujiie I, Shimizu S, Sato-Matsumura KC, Shimizu H.

J Eur Acad Dermatol Venereol. 2018 Nov 5. doi: 10.1111/jdv.15325. [Epub ahead of print]

PMID:
30394605
7.

The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes.

Kamaguchi M, Iwata H, Miyauchi T, Ujiie H, Ujiie I, Nomura T, Ohga N, Shimizu H, Kitagawa Y.

J Oral Pathol Med. 2019 Jan;48(1):60-67. doi: 10.1111/jop.12780. Epub 2018 Oct 24.

PMID:
30222210
8.

Autoantibodies undetectable by chemiluminescent enzyme immunoassay require extended antigen-antibody reaction time for detection.

Mai Y, Ujiie H, Higashi T, Yamagami J, Iwata H, Shimizu H.

Br J Dermatol. 2019 Jan;180(1):215-216. doi: 10.1111/bjd.17121. Epub 2018 Oct 10. No abstract available.

PMID:
30171687
9.

Mucosal substrates successfully identify the autoantigen in a case of mucous membrane pemphigoid.

Kamaguchi M, Iwata H, Ujiie H, Ohga N, Kitagawa Y, Shimizu H.

J Dtsch Dermatol Ges. 2018 Aug;16(8):1032-1034. doi: 10.1111/ddg.13618. No abstract available.

PMID:
30117705
10.

Schleimhautsubstrate identifizieren erfolgreich das Autoantigen bei einem Schleimhautpemphigoid.

Kamaguchi M, Iwata H, Ujiie H, Ohga N, Kitagawa Y, Shimizu H.

J Dtsch Dermatol Ges. 2018 Aug;16(8):1032-1035. doi: 10.1111/ddg.13618_g. No abstract available.

PMID:
30117697
11.

The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies.

Kamaguchi M, Iwata H, Nishie W, Toyonaga E, Ujiie H, Natsuga K, Kitagawa Y, Shimizu H.

Lab Invest. 2019 Jan;99(1):48-57. doi: 10.1038/s41374-018-0113-9. Epub 2018 Aug 8.

PMID:
30089857
12.

Case of anti-p200 pemphigoid accompanying uterine malignancy.

Hayashi M, Okamura K, Ujiie H, Iwata H, Suzuki T.

J Dermatol. 2018 Dec;45(12):e341-e342. doi: 10.1111/1346-8138.14473. Epub 2018 May 15. No abstract available.

PMID:
29766559
13.

Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.

Muramatsu K, Ujiie H, Kobayashi I, Nishie W, Izumi K, Ito T, Yoshimoto N, Natsuga K, Iwata H, Shimizu H.

J Allergy Clin Immunol. 2018 Dec;142(6):1818-1830.e6. doi: 10.1016/j.jaci.2018.03.014. Epub 2018 Apr 26.

PMID:
29704593
14.

Potential role of extracellular vesicle-mediated antigen presentation in Helicobacter pylori hypersensitivity during eradication therapy.

Ito T, Shiromizu T, Ohnishi S, Suzuki S, Mabe K, Hasegawa A, Ujiie H, Fujita Y, Sato Y, Terai S, Kato M, Asaka M, Tomonaga T, Shimizu H, Abe R.

J Allergy Clin Immunol. 2018 Aug;142(2):672-676.e12. doi: 10.1016/j.jaci.2018.02.046. Epub 2018 Apr 11. No abstract available.

PMID:
29653117
15.

Maculopapular drug eruption induced by linagliptin.

Zheng M, Yoshimoto N, Muramatsu K, Ito T, Ujiie H, Shimizu H.

Australas J Dermatol. 2018 Nov;59(4):e287-e288. doi: 10.1111/ajd.12818. Epub 2018 Apr 6. No abstract available.

PMID:
29624647
16.

Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients.

Mai Y, Nishie W, Izumi K, Yoshimoto N, Morita Y, Watanabe M, Toyonaga E, Ujiie H, Iwata H, Fujita Y, Nomura T, Sato-Matsumura KC, Shimizu S, Shimizu H.

Br J Dermatol. 2018 Sep;179(3):790-791. doi: 10.1111/bjd.16656. Epub 2018 Jun 25. No abstract available.

PMID:
29624639
17.

A case of red lunulae after haematopoietic stem cell transplantation.

Mai Y, Ujiie H, Iguchi A, Shimizu H.

Eur J Dermatol. 2018 Jun 1;28(3):407-409. doi: 10.1684/ejd.2018.3273. No abstract available.

PMID:
29624177
18.

Regulatory T cells in autoimmune skin diseases.

Ujiie H.

Exp Dermatol. 2018 Mar 25. doi: 10.1111/exd.13535. [Epub ahead of print]

PMID:
29575350
19.

High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa.

Kamaguchi M, Iwata H, Ujiie H, Natsuga K, Nishie W, Kitagawa Y, Shimizu H.

J Invest Dermatol. 2018 Aug;138(8):1707-1715. doi: 10.1016/j.jid.2018.03.002. Epub 2018 Mar 9.

PMID:
29530535
20.

A case of subepidermal autoimmune bullous disease with autoantibodies against 200 and 290-kDa antigens.

Sawada M, Hida T, Ujiie H, Iwata H, Uhara H.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e354-e355. doi: 10.1111/jdv.14927. Epub 2018 Mar 26. No abstract available.

PMID:
29524251

Supplemental Content

Loading ...
Support Center